Skip to content

Investigating the effectiveness of probiotics in the newborns

Investigating the effectiveness of probiotics in the treatment of jaundice in term and near_term newborns

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231020059774N1
Enrollment
100
Registered
2023-12-05
Start date
2023-11-22
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice in infants and acceleration of treatment. Neonatal jaundice from other and unspecified causes

Interventions

Intervention 1: Intervention group: 50 newborns with jaundice will be randomly given 5 drops of (Reuteflor ) probiotic daily and its effect on reducing the duration of hospitalization of infants compa

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Days to 28 Days

Inclusion criteria

Inclusion criteria: A newborn with a birth weight of more than 2 kg Childbirth age greater than 37 weeks Non-physiological jaundice and bilirubin more than 15 A newborn with bilirubin less than 25 A newborn doesnot need blood transfusion A newborn without abnormalities and comorbidities Parental consent

Exclusion criteria

Exclusion criteria: A newborn less than 2 days old Childbirth age less than 35 weeks Pathological jaundice A newborn with bilirubin above 20 A newborn with malformations and other co-morbidities A newborn needs a blood transfusion

Design outcomes

Primary

MeasureTime frame
Rapid decrease in bilirubin?. Timepoint: The beginning of hospitalization and the course of treatment and the time of discharge. Method of measurement: Bilirubin level in blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamereh Ghorbani

Shahid Beheshti University of Medical Sciences

samikh1985@yahoo.com009822227021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026